Lymphoma peripheral T-cell

Peripheral T-Cell lymphoma, not otherwise characterized AngioimmunoblasticT-cell lymphoma... 

Ishida T, Inagaki H, Utsunomiya A, et al. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res 2004 10 5494-5500. 

Woo S, Gardner ER, Chen X, Ockers SB, Baum CE, Sissung TM, Price DK, Erye R, Piekarz RL, Bates SE, Figg WD. (2009) Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma. Clin Cancer Res 15 1496-1503. 

B22. Boulland, M. L., Kanavaros, R, Wechsler, J., Casiraghi, O., and Gaulard, P., Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. J. Pathol. 183, 432-439 (1997). 

M., Miwa, H., Kita, K., etal. Immunohistochemical analysis of peripheral T-cell lymphoma in Japanese patients. Am. J. Clin. Pathol. 91,152—158 (1989). 

Depsipeptide II Cutaneous T-cell lymphoma, relapsed peripheral T-cell lymphoma NCI... 

Rituximab was suggested as a possible cause of aggressive peripheral T cell lymphoma in two patients 15 and 18 months after the nse of rituximab for low-grade B cell non-Hodgkin s lymphoma (23,24). 

Micallef IN, Kirk A, Norton A, Foran JM, Rohatiner AZ, Lister TA. Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma. Blood 1999 93(7) 2427-8. 

Tetreault S, Abler SL, Robbins B, Saven A. Peripheral T-cell lymphoma after anti-CD20 antibody therapy. J Clin Oncol 1998 16(4) 1635-7. 

LYMPHOEPITHELIOID CELL VARIANT OF PERIPHERAL T-CELL LYMPHOMA (LENNERT LYMPHOMA)... 

Suchi T, Lennert K, Tu LY, et al. Histopathology and immunohistochemistry of peripheral T cell lymphomas a proposal for their classification. J Clin Pathol. 1987 40 995-1015. 

BL, Burkitt lymphoma BLL, Burkitt-like lymphoma cHL, classical Hodgkin lymphoma IL, immunoblastic lymphoma LBL-B, lymphoblastic lymphoma precursor B-cell LBL-T, lymphoblastic lymphoma precursor T-cell LPL, lymphoplasmacytic lymphoma MM, multiple myeloma N, almost always negative PCLBL, primary cutaneous large B-cell lymphoma PEL, primary effusion lymphoma pHL, lymphocyte predominance Hodgkin lymphoma P-PTLD, polymorphic posttransplant lymphoproliferative disorders P-TCL, peripheral T-cell lymphoma PTLD, posttransplant lymphoproliferative disorders. 

A wastebasket category of post-thymic T-cell lymphomas, this group is best defined by what it is not (i.e., one of the specific peripheral T-cell lymphomas). 

Macon WR, Salhany KE. T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry. Am J Clin Pathol. 1998 109(5) 610-617. 

Dorfman DM, Shahsafaei A. CD69 expression correlates with expression of other markers of Thl T cell differentiation in peripheral T cell lymphomas. Hum Pathol. 2002 33(3) 330-334. 

Dorfman DM, van den Elzen P, Weng AP, et al. Differential expression of T-bet, a T-box transcription factor required for Thl T-cell development, in peripheral T-cell lymphomas. Am J Clin Pathol. 2003 120 866-873. 

Letmg CY, Ho FC, Srivastava G, et al. Usefulness of follictrlar dendritic cell pattern in classification of peripheral T-cell lymphomas. Histopathology. 1993 23(5) 433-437. 

Anagnostopoulos I, Hummel M, Firm T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 1992 80(7) 1804-1812. 

Hamilton-Dutoit SJ, Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin s lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol. 1992 140(6) 1315-1325. 

---